RARA and cancer: Selective RARα agonists have been shown to inhibit proliferation and induce apoptosis of mammary tumor oncogenesis in murine models (MMTV-neu and MMTV-wnt1 transgenic mice) relevant to human cancer,2 and to inhibit LPS-induced B-lymphocyte proliferation.3